Immatics is a biotechnology company focused on developing targeted immunotherapies for cancer patients, particularly in treating solid tumors. The company combines the discovery of cancer immunotherapy targets with the development of specific T cell receptors to enable a robust immune response. Immatics' pipeline includes Adoptive Cell Therapies and TCR Bispecifics, and it collaborates with global leaders in the pharmaceutical industry. The company's mission is to advance its therapies to improve the lives of cancer patients, and it maintains a strong commitment to innovation in immunotherapy technologies.
Discovery of HLA-restricted tumor-associated peptides as cancer targets β’ Biomarkers β’ Immunomonitoring β’ Peptidomics & mass spectrometry β’ Standardized PBMC collection
January 22
Oversee CMC activities for commercial strategies and launches of cell therapies at Immatics.
January 9
Join Immatics to oversee clinical monitoring and ensure compliant, quality trial operations in oncology.
September 15, 2024
Clinical Research Associate for cancer patient drug development at Immatics.
Remote Jobs at Immatics